Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs Glimepiride in MODY Patients
NCT01610934Phase 3Completed
- Sponsor
- Gentofte Hospital
- Start
- Aug 2012
- Primary completion
- Aug 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in Maturity Onset Diabetes of the Young (MODY), sponsored by Gentofte Hospital. Started Aug 2012; status: completed.
02
Drugs
03
Conditions
Maturity Onset Diabetes of the Young (MODY)
Beyond the preview
Go deeper on NCT01610934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610934.